Use of Sildenafil in Pulmonary Arterial Hypertension: Findings from a U.S. Healthcare Claims Database

Background: Pulmonary arterial hypertension (PAH) is a disease characterized by dyspnea, fatigue, chest pain and syncope. As there is no known cure for PAH, the goal of treatment is to control symptoms and slow disease progression. Sildenafil, a phosphodiesterase-5 inhibitor, has been indicated to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Ariel, Edelsberg, John, Teal, Simon, Mychaskiw, Marko A., Oster, Gerry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2014
Materias:
Cardiovascular Conditions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341821/
https://www.ncbi.nlm.nih.gov/pubmed/34430662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341821/
https://www.ncbi.nlm.nih.gov/pubmed/34430662

Ejemplares similares